Menu

Dr. Steven Ahrendt is currently a professor of Surgery-Surgical Oncology, as well as Director of Cytoreductive Surgery/HIPEC Program at University of Colorado Hospital and University of Colorado Cancer Center. He also practices at UCH Cancer Center.

With over 20 years of experience, Dr. Ahrendt treats a variety of diseases and conditions, including abdominal cancer, malignant mesothelioma and other abdominal malignancies. He has a particular speciality in using hyperthermic intraperitoneal chemotherapy (HIPEC), which has shown great success in treating peritoneal mesothelioma.

Dr. Ahrendt feels strongly about providing care to each patient that is personalized and compassionate to their individual case. He also seeks to guide patients through a comprehensive treatment plan, through their survivorship.

Other Interests & Specialties: Cancer surgery, colorectal cancer, gastroenterologic cancer, ovarian cancer, pancreatic cancer, sarcoma, malignant mesothelioma, pseudomyxoma peritonei, other abdominal malignancies and HIPEC treatment.

Certifications, Awards & Accolades: American College of Surgeons Fellow, Society of Surgical Oncology member

Education & Experience:

  • Medical Degree from the University of Chicago Division of the Biological Sciences The Pritzker School of Medicine
  • Internship at Johns Hopkins University School of Medicine
  • Residency at Johns Hopkins University School of Medicine
  • Fellowship at Johns Hopkins University School of Medicine

Publications:
Malignant Peritoneal Mesothelioma: Prognostic Factors and Oncologic Outcome AnalysisAnnals of Surgical Oncology. April 2014;21(4):1159–1165.

Institutional Learning Curve of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion for Peritoneal MalignanciesAnnals of Surgical Oncology. May 2015;22(5):1673–1679.

Preoperative inflammatory biomarkers and neurovegetative symptoms in peritoneal carcinomatosis patientsBrain, Behavior & Immunity. November 2014;42:65-68. doi: 10.1016/j.bbi.2014.06.019

Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion in Adolescent and Young Adults with Peritoneal MetastasesAnnals of Surgical Oncology. April 2017;24(4):875-883.

Photo of Dr. Steven Ahrendt

Get Help Contacting Dr. Steven Ahrendt


    Privacy policy: All information is secure and will never be released

    TRUSTe

    Free

    Mesothelioma Treatment Guide

    Please fill in the form to request our FREE Mesothelioma Treatment Guide.
    It will be sent to you within 24 hours.

    Free Mesothelioma Treatment Guide



      Privacy policy: All information is secure and will never be released

      TRUSTe